Skip to content

The Archive · A Source

BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial

PRNewswire 2024 www.prnewswire.com/news-releases/biolinerx-announces-first-patient-dosed-in-phase-1-clinical-trial-evaluating-motixafortide-for-cd34-hematopoietic-stem-cell-mobilization-for-gene-therapies-in-sickle-cell-disease-302020452.html